Edesa Biotech Reports Positive Exploratory Data for Paridiprubart in Patients with Acute Kidney Injury
Analyses demonstrate consistent positive signals across endpoints in AKI patients Findings derived from post hoc analysis of 101 patients also experiencing respiratory distress New data and analysis to be presented today at the 63rd European Renal Association Congress TORONTO, June 05, 2026 (GLOBE NEWSWIRE) — Edesa Biotech, Inc. (Nasdaq: EDSA), a clinical-stage biopharmaceutical company developing […]
Original Source
Read the full article at Financialpost →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.